Loading...
Market
Outcome of former McKinsey partner's legal case by mid-2025?
2
Resolution / Starting Odds
Guilty plea and sentencing • 25%
Not guilty verdict • 25%
Case dismissed • 25%
Ongoing legal proceedings • 25%
Court records and legal announcements
Story
McKinsey to Pay $650 Million to Settle DOJ Opioid Probe; Ex-Partner Pleads Guilty
Dec 13, 2024, 03:19 PM
McKinsey & Company has agreed to pay $650 million to settle U.S. Department of Justice criminal and civil investigations into its advisory work with opioid manufacturers, including Purdue Pharma, maker of OxyContin. The consulting firm accepted responsibility for its role in advising opioid producers on how to boost sales, including 'turbocharging' OxyContin sales, which prosecutors said contributed to the opioid epidemic. McKinsey entered into a five-year deferred prosecution agreement to resolve criminal charges, including conspiring with Purdue Pharma and others to aid and abet misbranding of prescription drugs. A former senior partner will plead guilty to obstruction of justice.
View original story
Similar markets
Guilty plea • 25%
Conviction after trial • 25%
Acquittal • 25%
Case dismissed • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No wrongdoing found • 25%
Minor violations found • 25%
Major violations found • 25%
Investigation inconclusive • 25%
Yes • 50%
No • 50%
Settlement finalized with over $500 million • 25%
Settlement finalized with exactly $500 million • 25%
Settlement finalized with less than $500 million • 25%
No settlement finalized by end of 2024 • 25%
No wrongdoing found • 25%
Minor violations identified • 25%
Major violations identified • 25%
Investigation inconclusive • 25%
Guilty of assault • 25%
Not guilty • 25%
Case dismissed • 25%
Other outcome • 25%
